Adcock’sdisposalofitsIndianpharmabusinesstoSamaraCapital

RMB is proud to have advised Adcock Ingram Holdings Limited, South Africa's leading pharmaceutical company, on the disposal of its Indian front ended formulations business ("Adcock India") through a management buy-in by Oaknet Lifesciences, a start-up pharmaceutical company owned by industry experts, supported by Samara Capital, a leading India-focused private equity fund.

RMB played an instrumental role in finding a suitable buyer consortium and delivering a transaction that helped Adcock Ingram achieve its strategic objectives. This INR 192 crore transaction endorses FirstRand Bank's capabilities in the healthcare sector and its ability to deliver investment banking solutions to clients not only in India but also on the lndo-Africa corridor.